<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-123795</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Association between venous thrombosis and dyslipidemia</dc:title>
<dc:description xml:lang="en">Background and objective: Venous and arterial thrombosis, despite being historically considered as distinct conditions, share certain risk factors. Dyslipidemia is a clinical condition with a relatively high prevalence in the population and has been associated with an increased thrombotic risk. Lipids and lipoproteins modulate the expression and/or function of thrombotic, &amp;#64257;brinolytic and rheological factors. Patients and method: We have developed a descriptive, retrospective, comparative, cross-sectional study including a group of 313 patients with venous thromboembolism (VTE). We collected basic demographic  data, cardiovascular risk factors and thrombotic complications. All patients were subjected to a lipid pro&amp;#64257;le study with determination of total cholesterol, high density lipoprotein cholesterol (cHDL), low density lipoprotein cholesterol (cLDL) and triglycerides. Results: The multivariable analysis showed that dyslipidemia was a risk factor for VTE (odds ratio [OR] 3.87, 95% con&amp;#64257;dence interval [95% CI] 2.72-5.56; P &lt; .0001). Of a total of 313 patients included in the study, 31% (n = 97) had a recurrent thrombotic event and 23% (n = 72) developed post-thrombotic syndrome. cHDL levels below 35 mg/dl and cLDL levels higher than 180 mg/dl represented risk factors  for the development of recurrent thrombosis, OR 3.12 (95% CI 1.35-7.74; P = .008) and OR 2.35 (95% CI  Background and objective: Venous and arterial thrombosis, despite being historically considered as distinct conditions, share certain risk factors. Dyslipidemia is a clinical condition with a relatively high prevalence in the population and has been associated with an increased thrombotic risk. Lipids and lipoproteins modulate the expression and/or function of thrombotic, &amp;#64257;brinolytic and rheological factors. Patients and method: We have developed a descriptive, retrospective, comparative, cross-sectional study   including a group of 313 patients with venous thromboembolism (VTE). We collected basic demographic data, cardiovascular risk factors and thrombotic complications. All patients were subjected to a lipid pro&amp;#64257;le study with determination of total cholesterol, high density lipoprotein cholesterol (cHDL), low density lipoprotein cholesterol (cLDL) and triglycerides.  Results: The multivariable analysis showed that dyslipidemia was a risk factor for VTE (odds ratio [OR] 3.87, 95% con&amp;#64257;dence interval [95% CI] 2.72-5.56; P &lt; .0001). Of a total of 313 patients included in the study, 31% (n = 97) had a recurrent thrombotic event and 23% (n = 72) developed post-thrombotic syndrome. cHDL levels below 35 mg/dl and cLDL levels higher than 180 mg/dl represented risk factors for the development of recurrent thrombosis, OR 3.12 (95% CI 1.35-7.74; P = .008) and OR 2.35 (95% CI 1.24-4.45; P = .008), respectively, and post-thrombotic syndrome, OR 3.44 (95% CI 1.43-8.83; P = .005) and OR 2.35 (95% CI 1.24-4.45; P = .008).  Conclusions: Our study confirmed the association between dyslipidemia and VTE and showed a risk of thrombosis nearly 4 times higher in individuals with this disease. In addition, alterations in the lipid profile were also related to a higher prevalence of thrombotic complications, recurrence and postthrombotic syndrome (AU)</dc:description>
<dc:creator>Llamas Sillero, M. Pilar</dc:creator>
<dc:creator>Ene, Gabriela</dc:creator>
<dc:creator>Vidal, Rosa</dc:creator>
<dc:creator>Miranda, Carolina</dc:creator>
<dc:creator>García Raso, Aránzazu</dc:creator>
<dc:creator>Mata, Raquel</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Fundamento y objetivo: La trombosis venosa y la trombosis arterial, a pesar de haber sido consideradas durante años como 2 entidades distintas, comparten ciertos factores de riesgo. La dislipidemia es una condición clínica con una prevalencia relativamente elevada en la población, que se ha asociado a un incremento del riesgo trombótico. Los lípidos y lipoproteínas modulan la expresión y/o función de factores trombóticos, fibrinolíticos y reológicos. Pacientes y método: Se ha desarrollado un estudio descriptivo, retrospectivo, comparativo y transversal en el que se ha incluido un grupo de 313 pacientes con enfermedad tromboembólica venosa (ETEV). Se recogieron los datos de filiación básica, factores de riesgo cardiovascular clásicos y complicaciones trombóticas. En todos los pacientes se estudió el perfil lipídico: colesterol total, colesterol unido a high density lipoproteins (HDL, «lipoproteínas de alta densidad»), colesterol unido a low density lipoproteins (LDL, «lipoproteínas de baja densidad») y triglicéridos. Resultados: La dislipidemia es un factor de riesgo para la ETEV, con una odds ratio (OR) de 3,87 (intervalo de confianza del 95% [IC 95%] 2,72-5,56; p &lt; 0,0001). El 31% (n = 97) de los pacientes sufrió un episodio recurrente y el 23% (n = 72) desarrolló síndrome postrombótico. Los valores de colesterol HDL &lt; 35 mg/dl y los de colesterol LDL &gt; 180 mg/dl resultaron ser factores de riesgo para el desarrollo de trombosis recurrente, con una OR de 3,12 (IC 95% 1,35-7,74; p = 0,008) y de 2,35 (IC 95% 1,24-4,45; p = 0,008), respectivamente, y síndrome postrombótico: OR 3,44 (IC 95% 1,43-8,83; p = 0,005) y OR 2,35 (IC 95% 1,24-4,45; p = 0,008). Conclusiones: Existe una asociación entre la dislipidemia y la ETEV, siendo el riesgo de trombosis casi 4 veces mayor en individuos con esta enfermedad. Las alteraciones del perfil lipídico también están relacionadas con una mayor prevalencia de recurrencia y síndrome postrombótico (AU)</dc:description>
<dc:source>Med. clín (Ed. impr.);143(1): 1-5, jul. 2014. tab</dc:source>
<dc:identifier>ibc-123795</dc:identifier>
<dc:title xml:lang="es">Asociación entre enfermedad tromboembólica venosa y dislipidemia</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d7152^s22080</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d3942^s22080</dc:subject>
<dc:subject>^d8230^s22062</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d52618^s22012</dc:subject>
<dc:subject>^d23925^s22080</dc:subject>
<dc:subject>^d52619^s22080</dc:subject>
<dc:subject>^d50514^s22012</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d9951^s22080</dc:subject>
<dc:subject>^d8252^s22062</dc:subject>
<dc:subject>^d51243</dc:subject>
<dc:type>article</dc:type>
<dc:date>201407</dc:date>
</metadata>
</record>
</ibecs-document>
